FDA moves to ease cancer drug shortage

02/21/2012 | USA Today

The FDA's Sandra Kweder reported that the agency and an Indian company have worked out a deal for the importation of a temporary replacement to Doxil, an essential cancer treatment that has been running short in the U.S. since June. The FDA also averted a shortage of the children's leukemia drug methotrexate by urging generic-drug makers to boost production, Kweder said.

View Full Article in:

USA Today

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ